Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

Risk factors, pathological and phenotypic features of male breast cancer in Greece.

Tsoukalas N, Moirogiorgou E, Tolia M, Pistamaltzian N, Bournakis E, Papadimitriou K, Demiri S, Panopoulos C, Koumakis G, Efremidis A; Hellenic Society for the Study of Breast Cancer (HES-BRECA).

Anticancer Res. 2014 Mar;34(3):1291-4.

PMID:
24596375
2.

A collecting duct carcinoma producing carcinoembryonic antigen and Ca-125 in a 29-year-old woman.

Tsoukalas N, Kostakis ID, Tolia M, Tryfonopoulos D, Lypas G, Panopoulos C, Barbounis V, Koumakis G, Efremidis A.

Int Urol Nephrol. 2014 Jul;46(7):1313-6. doi: 10.1007/s11255-014-0660-y. Epub 2014 Feb 15.

PMID:
24531923
3.

Complete remission of a reccurrent mesenteric liposarcoma with rare histological features following the administration of trabectedin.

Tsoukalas N, Tolia M, Lypas G, Panopoulos C, Barbounis V, Koumakis G, Efremidis A.

Oncol Lett. 2014 Jan;7(1):47-49. Epub 2013 Oct 29.

4.

Neoplastic pericarditis as the initial manifestation of a papillary thyroid carcinoma.

Tsoukalas N, Kostakis ID, Demiri S, Koumakis G, Barbounis V, Barbati K, Efremidis A.

Ups J Med Sci. 2013 Aug;118(3):196-8. doi: 10.3109/03009734.2013.801541. Epub 2013 May 23.

5.

Coexistence of intracranial germ cell tumor and craniopharyngioma in an adolescent: case report and review of the literature.

Tsoukalas N, Tolia M, Kostakis ID, Pistamaltzian N, Tryfonopoulos D, Lypas G, Koumakis G, Barbounis V, Goutas N, Efremidis A.

Int J Clin Exp Med. 2013;6(3):211-8. Epub 2013 Mar 21.

6.

A case of paraneoplastic autoimmune pancreatitis: mini-review of paraneoplastic syndromes in breast cancer.

Lekakis L, Tryfonopoulos D, Fakinos G, Panopoulos C, Theochari M, Koumakis G, Demiri S, Efremidis A.

Anticancer Res. 2012 Aug;32(8):3311-4. Review.

PMID:
22843907
7.

Salvage chemotherapy with cisplatin and 5-fluorouracil in metastatic breast cancer. Particular activity against liver metastases.

Lekakis L, Tryfonopoulos D, Pistamatzian N, Panopoulos C, Koumakis G, Demiri S, Efremidis A.

Anticancer Res. 2012 May;32(5):1833-7.

PMID:
22593470
8.

Adjuvant trastuzumab in HER2-positive breast cancer.

Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F, Bee V, Buyse M, Bendahmane B, Tabah-Fisch I, Lindsay MA, Riva A, Crown J; Breast Cancer International Research Group.

N Engl J Med. 2011 Oct 6;365(14):1273-83. doi: 10.1056/NEJMoa0910383.

9.

Validation and comparison of several published prognostic systems for patients with small cell lung cancer.

Paesmans M, Lafitte JJ, Lecomte J, Berghmans T, Efremidis A, Giner V, Van Cutsem O, Scherpereel A, Meert AP, Leclercq N, Van Houtte P, Sculier JP.

Eur Respir J. 2011 Sep;38(3):657-63. doi: 10.1183/09031936.00111110. Epub 2011 May 26.

10.

Insulin resistance: an independent risk factor for lung cancer?

Petridou ET, Sergentanis TN, Antonopoulos CN, Dessypris N, Matsoukis IL, Aronis K, Efremidis A, Syrigos C, Mantzoros CS.

Metabolism. 2011 Aug;60(8):1100-6. doi: 10.1016/j.metabol.2010.12.002. Epub 2011 Jan 19.

PMID:
21251684
11.

An in-frame exon-skipping MUTYH mutation is associated with early-onset colorectal cancer.

Fostira F, Papademitriou C, Efremidis A, Yannoukakos D.

Dis Colon Rectum. 2010 Aug;53(8):1197-201. doi: 10.1007/DCR.0b013e3181dcf0c1.

PMID:
20628285
12.

Elevated serum leptin levels: a risk factor for non-small-cell lung cancer?

Terzidis A, Sergentanis TN, Antonopoulos G, Syrigos C, Efremidis A, Polyzos A, Dessypris N, Petridou ET.

Oncology. 2009;76(1):19-25. doi: 10.1159/000177952. Epub 2008 Nov 24.

PMID:
19033693
13.

A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancer.

Sculier JP, Lafitte JJ, Efremidis A, Florin MC, Lecomte J, Berchier MC, Richez M, Berghmans T, Scherpereel A, Meert AP, Koumakis G, Leclercq N, Paesmans M, Van Houtte P; European Lung Cancer Working Party (ELCWP).

Ann Oncol. 2008 Oct;19(10):1691-7. doi: 10.1093/annonc/mdn354. Epub 2008 May 25.

PMID:
18504252
14.

Chemotherapy improves low performance status lung cancer patients.

Sculier JP, Lafitte JJ, Paesmans M, Lecomte J, Alexopoulos CG, Van Cutsem O, Giner V, Efremidis A, Berchier MC, Collon T, Meert AP, Scherpereel A, Ninane V, Koumakis G, Vaslamatzis MM, Leclercq N, Berghmans T; European Lung Cancer Working Party.

Eur Respir J. 2007 Dec;30(6):1186-92. Epub 2007 Aug 9.

15.

Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party.

Berghmans T, Lafitte JJ, Lecomte J, Alexopoulos CG, Van Cutsem O, Giner V, Efremidis A, Berchier MC, Collon T, Meert AP, Scherpereel A, Ninane V, Leclercq N, Paesmans M, Sculier JP; European Lung Cancer Working Party.

Br J Cancer. 2007 Jun 4;96(11):1644-9. Epub 2007 May 1.

16.

A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer.

Sculier JP, Lafitte JJ, Lecomte J, Alexopoulos CG, Van Cutsem O, Giner V, Efremidis A, Berchier MC, Collon T, Meert AP, Scherpereel A, Ninane V, Paesmans M, Berghmans T; European Lung Cancer Working Party.

Ann Oncol. 2007 Jun;18(6):1037-42. Epub 2007 Apr 2.

PMID:
17404152
17.

Pneumocystis carinii pneumonia in patients with solid tumors and lymphomas: predisposing factors and outcome.

Barbounis V, Aperis G, Gambletsas E, Koumakis G, Demiris M, Vassilomanolakis M, Efremidis A.

Anticancer Res. 2005 Jan-Feb;25(1B):651-5.

18.

First-line chemotherapy with docetaxel and cisplatin in metastatic breast cancer.

Vassilomanolakis M, Koumakis G, Barbounis V, Demiri M, Panopoulos C, Chrissohoou M, Apostolikas N, Efremidis AP.

Breast. 2005 Apr;14(2):136-41.

PMID:
15767183
19.

Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.

Berghmans T, Lafitte JJ, Thiriaux J, VanHoutte P, Lecomte J, Efremidis A, Koumakis G, Giner V, Richez M, Corhay JL, Wackenier P, Lothaire P, Mommen P, Ninane V, Sculier JP; European Lung Cancer Working Party.

Lung Cancer. 2004 Sep;45(3):339-48.

PMID:
15301874
20.

A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional non-small-cell lung cancer.

Sculier JP, Lafitte JJ, Berghmans T, Van Houtte P, Lecomte J, Thiriaux J, Efremidis A, Koumakis G, Giner V, Richez M, Corhay JL, Wackenier P, Lothaire P, Paesmans M, Mommen P, Ninane V; European Lung Cancer Working Party.

Ann Oncol. 2004 Mar;15(3):399-409.

PMID:
14998841

Supplemental Content

Loading ...
Support Center